Abstract
We thank Drs. Grzybowski and Kanclerz for their interest in our review article. Although the study performed by Fukuo and coworkers showed that the hand-held full-field flicker electroretinography device (RetEVAL, LKC Technologies Inc., Gaithersburg, MD; Welch Allyn, Inc., Skaneateles Falls, NY) was more convenient than conventional electroretinography for screening and grading of diabetic retinopathy (DR), the differences in the implicit times and amplitudes between normal subjects and patients without retinopathy were not significant. This could limit its usefulness at the preclinical stage of DR. 3 Fukuo M. Kondo M. Hirose A. et al. Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device. Sci Rep. 2016; 6: 36591 Crossref PubMed Scopus (43) Google Scholar Early detection of diabetic retinopathy with flicker electroretinography, proteomics, and oximetrySurvey of OphthalmologyVol. 64Issue 1PreviewWe would like to congratulate Safi and associates for presenting and discussing the very important issue of early detection of diabetic retinopathy (DR).6 The authors endeavor to describe all studies focused on subclinical biomarkers of DR, although we believe some supplementary information should be given. Full-Text PDF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
